Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma-Reference-Cited by-同舟云学术

Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma

Published:2017-02 Issue:2 Volume:27 Page:261-270
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Corrêa Nilton Lavatori¹,de Sá Lidia Vasconcellos²,de Mello Rossana Corbo Ramalho³

Affiliation:

1. Department of Nuclear Medicine, State Institute of Diabetes and Endocrinology (IEDE), Rio de Janeiro, Brazil.

2. Department of Medical Physics, Institute of Radiation Protection and Dosimetry, National Nuclear Energy Commission (IRD/CNEN), Rio de Janeiro, Brazil.

3. Department of Radiology, University Hospital of the Federal University of Rio de Janeiro (HUCFF/UFRJ), Rio de Janeiro, Brazil.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2016.0266

Reference36 articles.

1. International patterns and trends in thyroid cancer incidence, 1973–2002

2. Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors

3. Advances in our understanding of differentiated thyroid cancer

4. The changing epidemiology of thyroid cancer

5. Is radioiodine treatment for thyroid cancer a risk factor for second primary malignancies?

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histopathological changes in salivary glands after radioactive iodine treatment for thyroid diseases;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2024-09

2. Imaging‐based diagnosis and classification of radioactive iodine‐induced sialadenitis;Oral Diseases;2023-12-10

3. New insights into iodide metabolism based on preclinical models: impact on radiotherapy efficacy and protection against radioactive iodine exposure;2023-10-15

4. Multi-Omics and Management of Follicular Carcinoma of the Thyroid;Biomedicines;2023-04-19

5. Chronic Myeloid Leukemia following Exposure to Radioactive Iodine (I131): A Systematic Review;Oncology;2023